ALZM Could see a Monster Breakout This Week ! Must read
info@MonsterStox.com sent on 2011-04-05 16:50:54
Stocks Mentioned:
Share/Bookmark the Stock Market























 


































Dear Valued Subscriber,

ALZM shot up like a canon out of the gates today, seeing an increase of $0.16 cents from yesterday's close on significant trading volume!

 

We think ALZM could be poised for a major breakout very soon!

 

It is the 2nd day that ALZM reached $2.25! A breakout above that resistance level could mean massive upside!

 

We feel the strong action on ALZM could be due to the news we alerted you to last night stating that ALZM will be attending the annual meeting of the International Society for Heart and Lung Transplantation. 

 

At the conference it is expected that they will be reviewing the clinical trial protocols and discussing ongoing research!

 

For the last 2 days now we’ve seen ALZM make some impressive runs early in the day before leveling out during afternoon trading. While we’d love to see a company close with huge gains on a daily basis, we feel this activity still offers benefits.

 

The obvious reason we like how ALZM has traded is because most investors would be happy seeing gains of over 7% in a couple hours. On the other hand, with the stock leveling back out, we believe investors see new entry points where they can do it all over again!

 

With all of that said, we feel that ALZM's best days could be ahead of it!

 

This is not some fly by Night Company! 

 

ALZM is building a strong base at these levels and the next run could be around the corner!

 

Here are our Top 10 reasons why we believe short sellers may have underestimated ALZM as a company:



1. Organ Transport has been in existence for nearly 12 years, has had more than $10 million invested in it over the years in the research and development of the Lifecradle. 



2. ALZM has collaborated with OPOs, surgeons and research scientists from major academic medical centers and institutes across the nation, as well as in Australia and Europe.



3. The US medical supply industry is HOT, with annual revenues of around $75 Billion and it's not going anywhere!



4. Johnson & Johnson sees annual revenues of $17.7 Billion in their medical device and supply market alone!



5. According to phcconsulting.com, the core product categories are historically recession-resistant and will continue to grow regardless of still-restrictive credit market conditions that may ultimately affect spending decisions at the hospital customer base.



6. More than 100,000 men, women and children currently need life-saving organ transplants and every 10 minutes another name is added to the national organ transplant waiting list.



7. Only 27% of donated hearts and only 9% of donated lungs actually can be transplanted currently.



8. Because their product extends the life of these organs, ALZM could be in a position to literally save the lives of millions of people!



9. A key addition to the company occurred in 2006 when past U.S. Dept. of Health and Human Services Secretary Tommy Thompson, a strong advocate for organ donation and transplantation, joined the Board of Directors of Organ Transplant Systems, Inc.



10. PerkinElmer, Inc. (PKI), an industry peer, was trading around $13 in mid-2009 and recently has traded over $28!



We are continuing our Strong Announcement on ALZM and we encourage our subscribers to keep it on their radar!

 
Sincerely,












 























The Monsterstox.com Team









***** ***********************



GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY

We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.  Monsterstox.com's sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Monsterstox.com or an offer or solicitation to buy or sell any security.  Neither the owner of Monsterstox.com nor any of its members, officers, directors, contractors or employees is licensed
broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwrit ers . Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.   It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit Monsterstox.com. Monsterstox.com make s no recommendation that the
securities of the companies profiled or discussed in our releases or on our website should be purchased, sold o r held by investors. 

Please be advised that Monsterstox.com has not been compensated for the profile of ALZM. Please be advised that an affiliate of Monsterstox.com, Free P enny Alerts LLC, has entered into an agreement with Blithsome Inc. which calls for payment of $800,000 cash  to perform promotional and advertising services for a one week profile of Allezoe Medical Holdings (OTCBB:ALZM) which services include the issuance of this release and the other opinions that we release concerning  ALZM.   Monsterstox.com has not investigated the background of Blithsome Inc., the hiring company. Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own
shares of Allezoe Medical Holdings (OTCBB:ALZM) of which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price. monsterstox.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution ex penses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Allezoe Medical Holdings (OTCBB:ALZM) . Monsterstox.com is owned by: Golden Dragon Media Inc, 770 sherbrooke ouest Suite 1700, H3A 1G1, Montreal (Quebec), Canada. Questions regarding this release may be sent to info@ Monsterstox.com.



Notice of Stock Price Movements and Volatility

Viewers of this newsletter should understand that trading activity and stock prices  in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.



Notice of Affiliated and Non-Affiliated Newsletters

Monsterstox.com regularly shares research with two affiliated newsletters (“Affiliated Newsletters”) whose services have been retained to profile Allezoe Medical Holdings (OTCBB:ALZM) during Monsterstox.com’s profile period.  Monsterstox regularly coordinates the timing of the dissemination of its research reports with the two Affiliated Newsletters. It is also possible that other newsletters or profiles have been created by
sources we are unaware of. Viewers should take this into consideration when viewing any increased interest in Allezoe Medical Holdings (OTCBB:ALZM).



Some of the content in this release contains f orward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look f orward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any f orward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual
results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirem ents in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.



Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. More information can be received from the advertised companies' website www.allezoe.com . Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and t he Financial Industry Regulatory Authority ("FINRA") website at www.finra.org.   Any
investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. Monsterstox.com makes no representations, warranties or guarantees as to the acc uracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Monsterstox.com has no obligation to update any of the information
provided. Monsterstox.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.



From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or p enny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. Monsterstox.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is ba
s ed on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.



This release may provide hyperlinks to third party websites or access to third party content. Monsterstox.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Monsterstox.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that Monsterstox.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Monsterstox.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.



Monsterstox.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.



You agree to hold Monsterstox.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk.  Monsterstox.com disclaims all warranties of any kind, express or implied.



We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov  and/or then FINRA at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm.
 











This message was sent to from:
Stock Alerts | 770 sherbrooke ouest Suite 1700, H3A 1G1, Montreal (Quebec), Canada. | Montreal, Quebec H3A 1G1, Canada


Email Marketing by





Manage Your Subscription





***Visit the email's websites above for full disclaimer. The above email may have received compensation for stock picks.

Stocks Mentioned Today

Stock Market News